BIO
Bio-Rad Laboratories Inc. - Ordinary Shares - Class A

1,001
Mkt Cap
$7.97B
Volume
1.06M
52W High
$343.12
52W Low
$211.43
PE Ratio
-12.03
BIO Fundamentals
Price
$256.56
Prev Close
$292.42
Open
$251.00
50D MA
$307.61
Beta
0.89
Avg. Volume
234,402.15
EPS (Annual)
$27.85
P/B
1.17
Rev/Employee
$349,081.08
$7,928.17
Loading...
Loading...
News
all
press releases
Bio-Rad Laboratories (NYSE:BIO) Lowered to "Hold" Rating by Wall Street Zen
Wall Street Zen cut Bio-Rad Laboratories from a "buy" rating to a "hold" rating in a research note on Saturday...
MarketBeat·4h ago
News Placeholder
More News
News Placeholder
Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down - Here's What Happened
Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down - Should You Sell...
MarketBeat·15h ago
News Placeholder
Bio-Rad Laboratories (NYSE:BIO) Shares Gap Down After Earnings Miss
Bio-Rad Laboratories (NYSE:BIO) Shares Gap Down After Earnings Miss...
MarketBeat·19h ago
News Placeholder
Bio-Rad Laboratories Q4 Earnings Call Highlights
Bio-Rad Laboratories (NYSE:BIO) executives said the company finished 2025 within revised guidance for revenue and operating margin, but acknowledged that gross margin performance fell short of...
MarketBeat·1d ago
News Placeholder
Bio-Rad Laboratories (NYSE:BIO.B) Posts Quarterly Earnings Results
Bio-Rad Laboratories (NYSE:BIO.B - Get Free Report) announced its quarterly earnings data on Thursday. The company reported $2.51 earnings per share for the quarter. Bio-Rad Laboratories had a...
MarketBeat·1d ago
News Placeholder
Bio-Rad Laboratories (BIO) Q4 Earnings Miss Estimates
Bio-Rad (BIO) delivered earnings and revenue surprises of -2.34% and +0.01%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2d ago
News Placeholder
Bio-Rad Laboratories (NYSE:BIO) Announces Quarterly Earnings Results
Bio-Rad Laboratories (NYSE:BIO - Get Free Report) posted its earnings results on Thursday. The medical research company reported $2.51 earnings per share for the quarter, missing analysts' consensus...
MarketBeat·2d ago
News Placeholder
Earnings Summary: Bio-Rad Laboratories Q4
read more...
Benzinga·2d ago
News Placeholder
Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the fourth quarter and full-year...
Business Wire·2d ago
News Placeholder
Allianz Asset Management GmbH Boosts Position in Bio-Rad Laboratories, Inc. $BIO
Allianz Asset Management GmbH raised its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 22.7% during the 3rd quarter, according to its most recent disclosure with the Securities...
MarketBeat·7d ago
<
1
2
...
>

Latest BIO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.